SAN DIEGO, May 1, 2012 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced an antibody discovery partnership with Gilead Sciences, Inc.

Equity Research for the following companies: Human Genome Sciences (NASDAQ:HGSI), Gilead Sciences (NASDAQ:GILD), Bristol Myers Squibb (NYSE:BMY), CVR Energy (NYSE:CVI), UnitedHealth Group (NYSE:UNH), and US Airways Group (NYSE:LCC).

Equity Research for the following companies: SanDisk (NASDAQ:SNDK), Gilead Sciences (NASDAQ:GILD), Goldcorp (NYSE:GG), Newmont Mining (NYSE:NEM), EMC (NYSE:EMC), and Suncor Energy (NYSE:SU).

Equity Research for the following companies: Research In Motion (NASDAQ:RIMM), Gilead Sciences (NASDAQ:GILD), Express Scripts (NASDAQ:ESRX), Texas Instruments (NASDAQ:TXN), and Skyworks (NASDAQ:SWKS).

Equity Research for the following companies: Gilead Sciences (NASDAQ:GILD), Chesapeake Energy (NYSE:CHK), Wells Fargo (NYSE:WFC), Applied Materials (NASDAQ:AMAT), and Pfizer (NYSE:PFE).